Crossmark

3D-QSAR, drug-likeness, ADMET prediction, and molecular docking studies in silico of novel 5-oxo-1-thioxo-4,5-dihydro-1H-thiazolo[3,4-a]quinazoline derivatives as MALT1 protease inhibitors for the treatment of B cell lymphoma

Crossref DOI link: https://doi.org/10.1007/s11696-022-02627-w

Published Online: 2022-12-17

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haloui, Rachid https://orcid.org/0000-0002-3102-0229
Daoui, Ossama

Mkhayar, Khaoula

El Yaqoubi, Mohamed

Elkhattabi, Souad

Haoudi, Amal

Rodi, Youssef Kandri

Ouazzani, Fouad Chahdi

Chtita, Samir
License Information

Text and Data Mining valid from 2022-12-17

Version of Record valid from 2022-12-17
More Information

Article History

Received: 17 August 2022

Accepted: 8 December 2022

First Online: 17 December 2022

Declarations

:

: The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript. The authors declare that the article is original work, not published previously, without consideration for publication in another journal, approve the submission and have no conflicts to declare.

Document is current

Any future updates will be listed below